This weighed against a reduction of just 25 percent for the usual care group. All rights reserved. Neither of these ongoing parties endorse or suggest any commercial products, services, or equipment.. Aperio Technologies forges alliance with HistoRx to provide a whole-slide imaging system Aperio Technologies, Inc., , a worldwide innovator in digital pathology for the life span and healthcare sciences sector, and HistoRx, Inc., , a leader in the emerging field of tissue-based assays for targeted patient treatment, have entered right into a partnership to provide an integrated solution for whole-slide imaging with fluorescence. Aperio will be a value-added reseller of the AQUA software. Related StoriesDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixSupport for enteric nervous program pathology in prodromal PDLewy Body Composite Risk Score detects LBD and Parkinson's disease dementia in 3 minutesAperio CEO Dirk G.With multiple strains of the virus, it not merely could be mutating but also combining with other forms of the virus to make a strain ‘that looks not the same as either one,’ Cameron said . Kaisernetwork.org is serving while the official webcaster of the meeting. View the information to coverage and all webcasts, interviews and a daily video gather of conference highlights at This article is usually republished with kind authorization from our close friends at the The Kaiser Family members Foundation. You can view the complete Kaiser Daily Health Policy Report, search the archives, or join email delivery of in-depth coverage of wellness policy developments, debates and discussions.